Intensity Therapeutics Ownership | Who Owns Intensity Therapeutics?

Intensity Therapeutics Ownership Summary

Intensity Therapeutics is owned by 17.91% institutional investors, 8.34% insiders, and 73.75% retail investors. Vanguard group is the largest institutional shareholder, holding 3.44% of INTS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.44% of its assets in Intensity Therapeutics shares.

INTS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Intensity Therapeutics	17.91%	8.34%	73.75%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	649.08K	3.44%	$266.13K
Sentinus	495.91K	2.63%	$203.42K
Geode capital management	460.25K	2.44%	$188.79K
Mesirow financial investment management	251.00K	1.33%	$102.96K
Legacy advisors	153.45K	0.81%	$62.94K
Brown advisory	130.07K	0.69%	$31.57K
Jane street group	62.76K	0.33%	$25.74K
Warberg asset management	60.00K	0.32%	$14.56M
Sigma planning	56.43K	0.30%	$23.15K
Iht wealth management	47.48K	0.25%	$11.52K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sentinus	495.91K	0.02%	$203.42K
Legacy advisors	153.45K	0.01%	$62.94K
Ewa	41.35K	0.00%	$16.96K
One charles private wealth services	31.80K	0.00%	$13.04K
Warberg asset management	60.00K	0.00%	$14.56M
Sassicaia capital advisers	20.00K	0.00%	$4.85K
Mesirow financial investment management	251.00K	0.00%	$102.96K
Scientech research	24.73K	0.00%	$6.00K
Two sigma securities	18.45K	0.00%	$4.48K
Sigma planning	56.43K	0.00%	$23.15K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	649.08K	-	393.15K
Geode capital management	460.25K	-	201.36K
Legacy advisors	153.45K	0.01%	153.45K
Jane street group	62.76K	-	62.76K
Mesirow financial investment management	251.00K	0.00%	51.00K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-872.55K
Sapient capital	-	-	-650.15K
Ubs group	25.40K	-	-110.83K
Stonebridge financial group	-	-	-77.38K
Citigroup	88.00	-	-44.49K

New Positions

Holder	Shares	% Assets	Change	Value
Legacy advisors	153.45K	0.01%	153.45K	$62.94K
Iht wealth management	47.48K	0.00%	47.48K	$11.52K
Scientech research	24.73K	0.00%	24.73K	$6.00K
Sassicaia capital advisers	20.00K	0.00%	20.00K	$4.85K
Two sigma securities	18.45K	0.00%	18.45K	$4.48K

Sold Out

Holder	Change
Jpmorgan chase	-15.00
Fmr	-100.00
Cubist systematic strategies	-11.67K
Boothbay fund management	-15.00K
Qtr family wealth	-17.42K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	24	-7.69%	3,378,788	14.09%	17	7.27%	15	-	6	500.00%
Sep 30, 2025	25	-7.41%	2,956,433	49.41%	15	14.25%	15	-11.76%	1	-50.00%
Jun 30, 2025	27	28.57%	1,978,698	-23.56%	10	3.60%	17	54.55%	2	-50.00%
Mar 31, 2025	21	5.00%	2,588,459	-4.84%	17	4.46%	11	57.14%	4	-20.00%
Dec 31, 2024	20	-	2,720,161	56.32%	19	12.31%	7	16.67%	5	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	265.38K	1.44%	-
Vanguard Institutional Extnd Mkt Idx Tr	16.84K	0.66%	-
Fidelity Extended Market Index	10.98K	0.43%	-40.00
Fidelity Total Market Index	3.09K	0.12%	-
NT Ext Equity Mkt Idx Fd - L	67.81K	0.11%	59.98K
Fidelity Series Total Market Index	2.60K	0.10%	136.00
iShares Micro-Cap ETF	18.04K	0.10%	-
Spartan Total Market Index Pool G	1.52K	0.06%	-1.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 5	26.57K	0.04%	24.36K
Northern Trust Extended Eq Market Idx	7.82K	0.01%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

INTS Ownership FAQ

Who Owns Intensity Therapeutics?

Intensity Therapeutics shareholders are primarily institutional investors at 17.91%, followed by 8.34% insiders and 73.75% retail investors. The average institutional ownership in Intensity Therapeutics's industry, Biotech Stocks , is 382.13%, which Intensity Therapeutics falls below.

Who owns the most shares of Intensity Therapeutics?

Intensity Therapeutics’s largest shareholders are Vanguard group (649.08K shares, 3.44%), Sentinus (495.91K shares, 2.63%), and Geode capital management (460.25K shares, 2.44%). Together, they hold 8.51% of Intensity Therapeutics’s total shares outstanding.

Does Blackrock own Intensity Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Intensity Therapeutics.

Who is Intensity Therapeutics’s biggest shareholder by percentage of total assets invested?

Sentinus is Intensity Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 495.91K Intensity Therapeutics shares, valued at 203.42K$.

Who is the top mutual fund holder of Intensity Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Intensity Therapeutics shares, with 1.44% of its total shares outstanding invested in 265.38K Intensity Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools